Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.

Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.

This multi-centre UK study assesses the impact of predictive testing for breast and ovarian cancer predisposition genes (BRCA1/2) in the clinical context. In the year following predictive testing, 261 adults (59 male) from nine UK genetics centres participated; 91 gene mutation carriers and 170 nonc...

Full description

Bibliographic Details
Main Authors:	Watson, M, Foster, C, Eeles, R, Eccles, D, Ashley, S, Davidson, R, Mackay, J, Morrison, P, Hopwood, P, Evans, D
Format:	Journal article
Language:	English
Published:	2004

Similar Items

Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up.
by: Foster, C, et al.
Published: (2007)

Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations
by: Bancroft, E, et al.
Published: (2018)

Germline BRCA mutation and outcome in young onset breast cancer: POSH, a prospective cohort study
by: Copson, ER, et al.
Published: (2018)

Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers
by: Alan D McCrorie, et al.
Published: (2020-04-01)

BRCA and lynch syndrome-associated ovarian cancers behave differently
by: Neil A.J. Ryan, et al.
Published: (2017-11-01)

Psychosocial age assessments in the UK
by: Busler, D
Published: (2016)

Clinical features of BRCA-positive ovarian cancer
by: S. Ya. Maximov, et al.
Published: (2016-02-01)

BRCA1 and BRCA2 and Inherited Predisposition to Breast and Ovarian Cancers
by: Patricia N. Tonin
Published: (2002-12-01)

Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil
by: V.F. Esteves, et al.
Published: (2009-05-01)

RADIOTHERAPY IN MANAGEMENT OF BRCA-POSITIVE OVARIAN CANCER
by: T. V. Gorodnova, et al.
Published: (2017-09-01)

The BRCA Gene in Epithelial Ovarian Cancer
by: Luisa Sánchez-Lorenzo, et al.
Published: (2022-02-01)

Characterization of BRCA Deficiency in Ovarian Cancer
by: Giovanna Barbero, et al.
Published: (2023-02-01)

The contribution of LARGE genomic rearrangements of BRCA1 and BRCA2 gene mutations in breast and ovarian cancer families in a clinical cohort
by: Sawyer S, et al.
Published: (2012-04-01)

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
by: Roshni D. Kalachand, et al.
Published: (2020-09-01)

The characteristics of determination of BRCA1 and BRCA2 mutations in serous ovarian cancer
by: I A Demidova
Published: (2017-01-01)

Evaluation of germline BRCA1 and BRCA2 mutations in a multi-ethnic Asian cohort of ovarian cancer patients
by: Hasmad, HN, et al.
Published: (2015)

Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
by: Yomali Ferreyra, et al.
Published: (2023-08-01)

BRCA1 and BRCA2 Genetic Testing in Breast and/or Ovarian Cancer Families in Iran
by: Fatemeh Keshavarzi, et al.
Published: (2010-01-01)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
by: Ingrid Petroni Ewald, et al.
Published: (2016-06-01)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
by: Ingrid Petroni Ewald, et al.
Published: (2016-06-01)

Is no news good news? Inconclusive genetic test results in <it>BRCA1 </it>and <it>BRCA2 </it>from patients and professionals' perspectives
by: Ardern-Jones Audrey, et al.
Published: (2010-01-01)

BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers
by: Osman K., et al.
Published: (2022-12-01)

Low-level constitutional mosaicism of BRCA1 in two women with young onset ovarian cancer
by: B. Speight, et al.
Published: (2022-09-01)

Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations.
by: Nicolai Juul Birkbak, et al.
Published: (2013-01-01)

Frequency of BRCA1 and BRCA2 mutations in ovarian cancer patients in South-East Poland
by: Andrzej Jasiewicz, et al.
Published: (2022-04-01)

Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families
by: Kang, P., et al.
Published: (2010)

Psychosocial age assessments in the UK
by: Debbie Busler
Published: (2016-05-01)

BRCA Mutations—The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers
by: Anna P. Loboda, et al.
Published: (2023-03-01)

Penetrance estimates for <it>BRCA1 </it>and <it>BRCA2 </it>based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family
by: Lalloo Fiona, et al.
Published: (2008-05-01)

Psychosocial Interventions for Women with a <i>BRCA1</i> or <i>BRCA2</i> Mutation: A Scoping Review
by: Talin Boghosian, et al.
Published: (2021-03-01)

BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside
by: Stergios Boussios, et al.
Published: (2022-08-01)

BRCA mutation in high grade epithelial ovarian cancers
by: Tarinee Manchana, et al.
Published: (2019-08-01)

High rate of mutations in the BRCA1, BRCA2, CHEK2, NBN, and BLM genes in Russian ovarian cancer patients
by: Ye. I. Bateneva, et al.
Published: (2015-01-01)

Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients
by: Yunuo Zhang, et al.
Published: (2022-08-01)

Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
by: Bielecka Helena, et al.
Published: (2012-04-01)

Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
by: Bielecka Helena, et al.
Published: (2012-01-01)

Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcome
by: Ashour M, et al.
Published: (2019-07-01)

Sequence Variants of BRCA1 and BRCA2 Genes in Four Iranian Families with Breast and Ovarian Cancer
by: F Keshavarzi, et al.
Published: (2011-06-01)

Sequence Variants of BRCA1 and BRCA2 Genes in Four Iranian Families with Breast and Ovarian Cancer
by: F Keshavarzi, et al.
Published: (2011-06-01)

Beyond breast and ovarian cancers: PARP inhibitors for BRCA mutation-associated and BRCA-like solid tumors
by: Ciara C. O'Sullivan, et al.
Published: (2014-02-01)